全文获取类型
收费全文 | 13002篇 |
免费 | 724篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 216篇 |
儿科学 | 334篇 |
妇产科学 | 456篇 |
基础医学 | 2279篇 |
口腔科学 | 299篇 |
临床医学 | 1250篇 |
内科学 | 2294篇 |
皮肤病学 | 283篇 |
神经病学 | 1229篇 |
特种医学 | 499篇 |
外国民族医学 | 1篇 |
外科学 | 2038篇 |
综合类 | 172篇 |
一般理论 | 4篇 |
预防医学 | 696篇 |
眼科学 | 243篇 |
药学 | 695篇 |
中国医学 | 15篇 |
肿瘤学 | 773篇 |
出版年
2023年 | 107篇 |
2022年 | 164篇 |
2021年 | 254篇 |
2020年 | 176篇 |
2019年 | 263篇 |
2018年 | 288篇 |
2017年 | 257篇 |
2016年 | 303篇 |
2015年 | 337篇 |
2014年 | 380篇 |
2013年 | 548篇 |
2012年 | 774篇 |
2011年 | 799篇 |
2010年 | 438篇 |
2009年 | 433篇 |
2008年 | 748篇 |
2007年 | 714篇 |
2006年 | 641篇 |
2005年 | 694篇 |
2004年 | 641篇 |
2003年 | 610篇 |
2002年 | 580篇 |
2001年 | 221篇 |
2000年 | 165篇 |
1999年 | 185篇 |
1998年 | 122篇 |
1997年 | 116篇 |
1996年 | 89篇 |
1995年 | 77篇 |
1994年 | 83篇 |
1993年 | 57篇 |
1992年 | 66篇 |
1991年 | 97篇 |
1990年 | 73篇 |
1989年 | 67篇 |
1988年 | 78篇 |
1987年 | 60篇 |
1986年 | 65篇 |
1985年 | 59篇 |
1984年 | 56篇 |
1982年 | 59篇 |
1980年 | 52篇 |
1979年 | 47篇 |
1978年 | 41篇 |
1977年 | 41篇 |
1976年 | 45篇 |
1975年 | 50篇 |
1974年 | 52篇 |
1973年 | 60篇 |
1926年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
Platelet interactions with calcium-phosphate-coated surfaces 总被引:1,自引:0,他引:1
Many studies have shown that calcium-phosphate (CaP)-coated endosseous implants exhibit more peri-implant bone formation and bone contact at early healing times than uncoated implants. Since the rate of healing is influenced by blood/implant interactions and possibly the degree of blood platelet activation, the aim of this study was to determine whether the topography, microtopography, or the presence of calcium (Ca) and phosphate (PO(4)) ions in the implant surface plays a predominant role in platelet activation. We define the threshold between topography and microtopography as the limit of the scale range of platelets themselves; thus, a microtopographic surface is defined by one which exhibits features 3mum. With the help of four international collaborating laboratories, we prepared 11 titanium and CaP-modified titanium surfaces each with different (micro)topographies and interrogated these surfaces with both platelet adhesion (lactate dehydrogenase activity) and platelet activation (microparticle formation and P-selectin expression) assays. Our results show that: calcium (Ca)- and phosphate (PO(4))-containing surfaces of increasing surface microtopographical complexity exhibit increasing platelet activation; surfaces with similar surface microtopographies show similar levels of platelet activation regardless of the presence of Ca and PO(4) in the surface; and that surface microtopography is responsible for platelet activation rather than the presence of Ca and PO(4) in the surface. 相似文献
72.
Sabina Rak MD PhD Anette Bjrnson MSc Lena Hkanson MSc PhD Sverre Srenson MD PhD Per Venge MD PhD 《The Journal of allergy and clinical immunology》1991,88(6):878-888
Two groups of birch pollen--allergic patients with seasonal rhinoconjunctivitis and asthma were followed during two consecutive birch-pollen seasons, one group, N = 10, during a season with high pollen load, and one group, N = 15, during a season of low pollen load. Half the patients were treated with immunotherapy (IT) for 3 and 4 years, respectively. The other half of the patients served as control group (non-IT). Bronchoalveolar lavage (BAL) was performed once before each season and once during the pollen season. Eosinophil (EOS) numbers in BAL were increased (p less than 0.01) during the season with high pollen load but not in the season with a low pollen load, and this increment was absent in the IT-treated group. Also, the EOS cationic protein levels were raised in the non-IT-treated group during the season with a high pollen load. The levels of EOS and neutrophil chemotactic activity were raised in BAL in both seasons in the non-IT-treated group compared with the IT-treated group (p less than 0.02, p less than 0.003, p less than 0.04, and p less than 0.005 in high- and low-load pollen season, respectively). Serum and BAL eosinophil chemotactic activity (ECA) were positively correlated (p less than 0.001). We conclude that there is an influx of active EOSs into the lung of pollen-allergic patients with asthma during a pollen season, which may be abrogated by IT. Furthermore, the generation of ECA appears to be an extremely sensitive marker of antigenic exposure, and the potent inhibition of the generation of ECA by IT may provide a clue as to the mechanism of this treatment. 相似文献
73.
Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps 总被引:3,自引:0,他引:3
Benson M Carlsson L Adner M Jernås M Rudemo M Sjögren A Svensson PA Uddman R Cardell LO 《The Journal of allergy and clinical immunology》2004,113(6):58-1143
BACKGROUND: Treatment with local glucocorticoids (GCs) decreases symptoms and the size of nasal polyps. This might depend on the downregulation of proinflammatory genes, as well as the upregulation of anti-inflammatory genes. OBJECTIVE: We sought to identify GC-regulated anti-inflammatory genes in nasal polyps. METHODS: Affymetrix DNA microarrays were used to analyze the expression of 22,283 genes in 4 nasal polyps before and after local treatment with fluticasone (400 microg/d). Expression of uteroglobin and mammaglobin B was analyzed with real-time PCR in 6 nasal polyps and in nasal biopsy specimens from 6 healthy control subjects. RESULTS: Two hundred three genes had changed in expression in treated polyps, and 139 had known functions: 54 genes were downregulated, and 85 were upregulated. Genes associated with inflammation constituted the largest single functional group. These genes affected key steps in inflammation (eg, immunoglobulin production; antigen processing and presentation; and the chemoattraction and activation of granulocytes, T cells, and B cells). Several proinflammatory genes were downregulated. In contrast, some anti-inflammatory genes were upregulated. The gene that increased most in terms of expression was uteroglobin. This was confirmed with real-time PCR. By contrast, expression of uteroglobin was lower in untreated polyps than in healthy nasal mucosa. Immunohistochemical investigation showed staining of uteroglobin in the epithelium and in seromucous glands in control subjects and in nasal polyps. CONCLUSION: Upregulation of anti-inflammatory genes, such as uteroglobin, might contribute to the effects of local treatment with GCs in nasal polyps. 相似文献
74.
75.
This study discusses three software tools, the first two aid in integrating sequence with an FPC physical map and the third automatically selects a minimal tiling path given genomic draft sequence and BAC end sequences. The first tool, FSD (FPC Simulated Digest), takes a sequenced clone and adds it back to the map based on a fingerprint generated by an in silico digest of the clone. This allows verification of sequenced clone positions and the integration of sequenced clones that were not originally part of the FPC map. The second tool, BSS (Blast Some Sequence), takes a query sequence and positions it on the map based on sequence associated with the clones in the map. BSS has multiple uses as follows: (1) When the query is a file of marker sequences, they can be added as electronic markers. (2) When the query is draft sequence, the results of BSS can be used to close gaps in a sequenced clone or the physical map. (3) When the query is a sequenced clone and the target is BAC end sequences, one may select the next clone for sequencing using both sequence comparison results and map location. (4) When the query is whole-genome draft sequence and the target is BAC end sequences, the results can be used to select many clones for a minimal tiling path at once. The third tool, pickMTP, automates the majority of this last usage of BSS. Results are presented using the rice FPC map, BAC end sequences, and whole-genome shotgun from Syngenta. 相似文献
76.
Berhane K Karim R Cohen MH Masri-Lavine L Young M Anastos K Augenbraun M Watts DH Levine AM 《Journal of acquired immune deficiency syndromes (1999)》2004,37(2):1245-1252
BACKGROUND: Anemia is common in HIV-infected individuals and may be associated with decreased survival. OBJECTIVE: To ascertain the impact of highly active antiretroviral therapy (HAART) on anemia and the relationship between anemia and overall survival in HIV-infected women. METHODS: A prospective multicenter study of HIV-1 infection in women. Visits occurred every 6 months, including a standardized history, physical examination, and comprehensive laboratory evaluation. The setting was a university-affiliated clinic at 6 sites in the United States. Participants were 2056 HIV-infected women from the Women's Interagency HIV Study (WIHS). The outcome measure was anemia, defined as hemoglobin (Hb) <12 g/dL. Survival analysis was based on overall mortality during the follow-up period. RESULTS: Among HIV-infected women who were not anemic at baseline, 47% became anemic by 3.5 years of follow-up. On multivariate analysis, the use of HAART was associated with resolution of anemia even when used for only 6 months (odds ratio [OR] = 1.45; P < 0.05). In the multivariate model, a CD4 cell count <200 cells/microL (OR = 0.56; P < 0.001); HIV-1 RNA level > or =50,000 copies/mL (OR = 0.65; P < 0.001), and mean corpuscular volume (MCV) value <80 fL (OR = 0.40; P < 0.001) were also associated with an inability to correct anemia. Similarly, use of HAART for 12 months or more was associated with a protective effect against development of anemia (OR = 0.71; P < 0.001). Among HIV-infected women, anemia was independently associated with decreased survival (hazard ratio [HR] = 2.58; P < 0.001). Other factors associated with decreased survival included a CD4 cell count <200 cells/microL (HR = 5.83; P < 0.001), HIV-1 RNA level > or = 50,000 copies/mL (HR = 2.12; P < 0.001), and clinical diagnosis of AIDS (HR = 2.83; P < 0.001). CONCLUSIONS: Anemia is an independent risk factor for decreased survival among HIV-infected women. HAART therapy for as little as 6 months is associated with resolution of anemia. 相似文献
77.
Pham MT Maitz MF Reuther H Muecklich A Prokert F Steiner G 《Journal of biomedical materials research. Part A》2004,71(1):16-24
The native extracellular matrix (ECM) laid down on silicon and titanium surfaces by osteoblast-like SAOS-2 cells was exposed by selective removal of cells. This type of material surface ECM-Si, ECM-Ti was shown to promote the nucleation of calcium phosphate from a simulated body fluid (SBF). Microscopic and spectroscopic results revealed the effect was associated with a collagen fiber-free extracellular matrix. 相似文献
78.
Kinetic studies of neutrophil phagocytosis: V. Studies on the co-operation between the Fc and C3b receptors 总被引:4,自引:0,他引:4 下载免费PDF全文
The co-operation between the Fc and C3b receptors of PMNs (neutrophil granulocytes) during phagocytosis has been studied by the effect of interference with either of the receptors. The significance of the Fc receptor for the mediation of internalization proposed by previous investigators was confirmed by the inhibition of both Fc- and C3b-mediated phagocytosis by Fc fragments of IgG and by Fab fragments of antiserum against the Fc part of IgG. C3b-receptor-mediated phagocytosis was inhibited by trypsin, granulocyte elastase, myeloperoxidase and H2O2. High concentrations of elastase and the combined action of H2O2 and myeloperoxidase generated a C3b-receptor dysfunction, which implied that the destruction of C3b-receptor function also disturbed Fc-receptor function. The demonstrated C3b receptor dysfunction indicated that the Fc and C3b receptors were closely situated in the cellular membrane of the PMN. A hypothesis for co-operation between the two receptor types would be that the C3b receptor initially facilitates the adherence of an IgG-C3b-coated particle. Secondly, the C3b receptor would facilitate the IgG-Fc-receptor contact either by some kind of structural derangement to permit the entrance of the IgG-C3b complex or by removal of C3b from the Fc part of IgG. 相似文献
79.
Horak F Stübner UP Zieglmayer R Harris AG 《The Journal of allergy and clinical immunology》2002,109(6):956-961
BACKGROUND: Unlike many antihistamines, desloratadine can reduce nasal congestion in patients with seasonal allergic rhinitis (SAR). OBJECTIVE: We compared the effects of 5 mg of desloratadine and placebo on nasal airflow and SAR symptoms, including nasal congestion, in response to grass pollen in an allergen-exposure unit. METHODS: In a randomized, double-blind, placebo-controlled, crossover trial, 47 subjects with histories of SAR received desloratadine or placebo every morning for 7 days and, after a 10-day washout period, were crossed over to the other treatment arm for 7 days. Subjects underwent a 6-hour allergen exposure on day 7 of each treatment period. Nasal airflow and nasal secretion weights were measured before and every 30 minutes during allergen exposure; SAR symptoms (including nasal congestion) were scored before exposure and every 15 minutes thereafter. RESULTS: Nasal obstruction, as measured by nasal airflow, was less severe with desloratadine than with placebo (P <.02). Individual and combined SAR symptom severity scores, including nasal congestion and sneezing, were significantly lower with desloratadine than with placebo (all P < or =.003). Within 30 minutes of allergen exposure, less severely decreased nasal airflow (P <.02), less nasal secretions (P <.001), and less severe symptoms, including nasal congestion (P <.002), rhinorrhea, and sneezing, occurred with desloratadine compared with placebo, and this continued throughout (0-6 hours) allergen exposure. Desloratadine was well tolerated, with an adverse event profile similar to that of placebo. CONCLUSION: In subjects with allergen-induced SAR symptoms, desloratadine significantly reduced the severity of nasal obstruction and accompanying complaints of nasal congestion and other SAR symptoms compared with the effects of placebo. 相似文献
80.
Charles Frèche Francisque Leynadier Friedrich Horak David Hide Fernando Duce Gracia Manfred Goos Claus Bachert Attila Horvath Eva Antosova Muriel Verrecchia Paul Ben Soussen 《Annals of allergy, asthma & immunology》2002,89(3):304-310
BACKGROUND: Mizolastine is a nonsedating H1 histamine receptor antagonist with additional antiallergic properties currently marketed in Europe for the treatment of seasonal and perennial allergic rhinitis (PAR) and urticaria. OBJECTIVE: This multicenter, randomized, double-blind, parallel-group study was conducted to evaluate the efficacy and safety of mizolastine in PAR compared with loratadine and placebo. METHODS: After a 1-week placebo run-in period, 428 adult PAR patients received placebo (146 of 428), mizolastine 10 mg (141 of 428), or loratadine 10 mg (141 of 428) once daily for 28 days. Symptoms were evaluated by patients and physicians using a total nasal score, evaluating itching, rhinorrhea, nasal blockade, and sneezing severity. RESULTS: Mizolastine treatment resulted in a significantly greater decrease in patient-rated total nasal score than placebo after 2 weeks (D14; -42%, P < 0.001) and at the end of the treatment period (-46%, P = 0.01), and significantly greater than that observed with loratadine at D14 (P = 0.031). No significant difference in change in total nasal score was observed between loratadine and placebo at 2- and 4-week visits. The global safety was satisfactory and the incidence of adverse events was similar in the three treatment groups. CONCLUSIONS: Mizolastine provides effective symptom relief in PAR together with a satisfactory safety profile. Improvement with mizolastine was significantly greater than placebo throughout the study despite a large placebo effect. Also mizolastine's effects were greater those observed with loratadine after 2 weeks of treatment. 相似文献